title: [Rosiglitazone in two patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer: preliminary results].
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Virgen Macarena, Sevilla, España.
authors.forename: Tomás
authors.initials: T
authors.lastname: Martín
authors.forename: Alberto
authors.initials: A
authors.lastname: Torres
authors.forename: Teresa
authors.initials: T
authors.lastname: Cambil
authors.forename: Juan
authors.initials: J
authors.lastname: Castro
mesh_terms: D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D008875:Middle Aged; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use*; D013954:Thyroglobulin / Q000097:blood* / Q000276:immunology; D013961:Thyroid Gland / Q000473:pathology; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology
chemical_list: D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D007457:Iodine Radioisotopes; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D013954:Thyroglobulin